Eric Ribner | executive |
John Gillard | executive |
Des Fitzgerald | executive |
James Sidoti | analyst |
Paul Nouri | analyst |
Greetings. Welcome to Trinity Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] Please note, this conference is being recorded. At this time, I'll now turn the conference over to Eric Ribner with Investor Relations. Eric, you may now begin.